Health tech company working on early detection of lung cancer, Qure.ai has won £3.2 million from the U.K. governement’s Small Business Research Initiative Healthcare.
The Small Business Research Initiative grant is provided in partnership with the NHS Cancer Programme and the Accelerated Access Collaborative. The SBRI competition was launched in March 2021. Qure.ai was among the eight startups that received funding for their projects that assist in faster and earlier detection and diagnosis of cancer.
The fresh capital will be used to conduct a research programme analysing the detection of lung nodules on chest X-rays that are indicative of lung cancer to gather evidence and better understand the feasibility of AI triage of questionable chest X-rays for prompt reporting.
Prashant Warier, CEO and Co-founder said: “Lung cancer is the leading cause of death in the U.K. Its aggressive nature and absence of early, visible signs often leads to diagnostic and treatment delays and poor outcomes. The 5-year survival rates remain low at roughly 14%, with 30% of patients dying within 90 days after diagnosis. Identifying it at earlier stages impacts survival rates positively and allows for the ability to use less toxic treatment or intervention. However, this is difficult because of varying protocols and immense workloads. The use of AI technologies can help in early detection of potentially cancerous nodules from chest X-rays.”
The startup’s cancer detection solution is available in more than 50 countries at 500 sites globally and caters to four million patients.
Would you like to write the first comment?Login to post comments